Radiation treatment monitoring using multimodal functional imaging: PET/CT (18F-Fluoromisonidazole & 18F-Fluorocholine) and DCE-US. Issue 1 (December 2015)
- Record Type:
- Journal Article
- Title:
- Radiation treatment monitoring using multimodal functional imaging: PET/CT (18F-Fluoromisonidazole & 18F-Fluorocholine) and DCE-US. Issue 1 (December 2015)
- Main Title:
- Radiation treatment monitoring using multimodal functional imaging: PET/CT (18F-Fluoromisonidazole & 18F-Fluorocholine) and DCE-US
- Authors:
- Arteaga-Marrero, Natalia
Brekke Rygh, Cecilie
Mainou-Gomez, Jose
Adamsen, Tom
Lutay, Nataliya
Reed, Rolf
Olsen, Dag - Abstract:
- Abstract Background This study aims to assess the effect of radiation treatment on the tumour vasculature and its downstream effects on hypoxia and choline metabolism using a multimodal approach in the murine prostate tumour model CWR22. Functional parameters derived from Positron Emission Tomography (PET)/Computer Tomography (CT) with18 F-Fluoromisonidazole (18 F-FMISO) and18 F-Fluorocholine (18 F-FCH) as well as Dynamic Contrast-Enhanced Ultrasound (DCE-US) were employed to determine the relationship between metabolic parameters and microvascular parameters that reflect the tumour microenvironment. Immunohistochemical analysis was employed for validation. Methods PET/CT and DCE-US were acquired pre- and post-treatment, at day 0 and day 3, respectively. At day 1, radiation treatment was delivered as a single fraction of 10 Gy. Two experimental groups were tested for treatment response with18 F-FMISO and18 F-FCH. Results The maximum Standardized Uptake Values (SUVmax) and the mean SUV (SUVmean) for the18 F-FMISO group were decreased after treatment, and the SUVmean of the tumour-to-muscle ratio was correlated to microvessel density (MVD) at day 3. The kurtosis of the amplitude of the contrast uptakeA was significantly decreased for the control tumours in the18 F-FCH group. Furthermore, the eliminating rate constant of the contrast agent from the plasmak el derived from DCE-US was negatively correlated to the SUVmean of tumour-to-muscle ratio, necrosis and MVD. ConclusionsAbstract Background This study aims to assess the effect of radiation treatment on the tumour vasculature and its downstream effects on hypoxia and choline metabolism using a multimodal approach in the murine prostate tumour model CWR22. Functional parameters derived from Positron Emission Tomography (PET)/Computer Tomography (CT) with18 F-Fluoromisonidazole (18 F-FMISO) and18 F-Fluorocholine (18 F-FCH) as well as Dynamic Contrast-Enhanced Ultrasound (DCE-US) were employed to determine the relationship between metabolic parameters and microvascular parameters that reflect the tumour microenvironment. Immunohistochemical analysis was employed for validation. Methods PET/CT and DCE-US were acquired pre- and post-treatment, at day 0 and day 3, respectively. At day 1, radiation treatment was delivered as a single fraction of 10 Gy. Two experimental groups were tested for treatment response with18 F-FMISO and18 F-FCH. Results The maximum Standardized Uptake Values (SUVmax) and the mean SUV (SUVmean) for the18 F-FMISO group were decreased after treatment, and the SUVmean of the tumour-to-muscle ratio was correlated to microvessel density (MVD) at day 3. The kurtosis of the amplitude of the contrast uptakeA was significantly decreased for the control tumours in the18 F-FCH group. Furthermore, the eliminating rate constant of the contrast agent from the plasmak el derived from DCE-US was negatively correlated to the SUVmean of tumour-to-muscle ratio, necrosis and MVD. Conclusions The present study suggests that the multimodal approach using18 F-FMISO PET/CT and DCE-US seems reliable in the assessment of both microvasculature and necrosis as validated by histology. Thus, it has valuable diagnostic and prognostic potential for early non-invasive evaluation of radiotherapy. … (more)
- Is Part Of:
- Journal of translational medicine. Volume 13:Issue 1(2015)
- Journal:
- Journal of translational medicine
- Issue:
- Volume 13:Issue 1(2015)
- Issue Display:
- Volume 13, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 13
- Issue:
- 1
- Issue Sort Value:
- 2015-0013-0001-0000
- Page Start:
- 1
- Page End:
- 10
- Publication Date:
- 2015-12
- Subjects:
- PET/CT -- 18F-Fluoromisonidazole -- 18F-FMISO -- 18F-Fluorocholine -- 18F-FCH -- DCE-US -- CWR22
Medicine, Experimental -- Periodicals
Human experimentation in medicine -- Periodicals
Therapeutics -- Periodicals
615.50724 - Journal URLs:
- http://www.pubmedcentral.gov/tocrender.fcgi?journal=214 ↗
http://www.translational-medicine.com/home/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s12967-015-0708-5 ↗
- Languages:
- English
- ISSNs:
- 1479-5876
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9891.xml